Assessment after diagnosis
Determining suitability for radical treatment of histologically-confirmed oesophageal or gastro-oesophageal junctional cancer after endoscopy and wholebody CT scan diagnosis
- F-18 FDG PET-CT should be offered to people with oesophageal and gastro-oesophageal junctional tumours that are suitable for radical treatment (except for T1a tumours)
- do not offer endoscopic ultrasound only to distinguish between T2-T3 tumours in people with oesophageal and gastro-oesophageal junctional tumours
- endoscopic ultrasound should only be offered to people with oesophageal and gastrooesophageal junctional cancer when it will help guide ongoing management
- staging laparoscopy should only considered for people with oesophageal or gastrooesophageal junctional cancer when it will help guide ongoing management.
HER2 testing in metastatic oesophago-gastric adenocarcinoma
- HER2 testing should be offered to people with metastatic oesophago-gastric adenocarcinoma
Reference:
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.